Limited-duration Teclistamab
Condition(s):Myeloma MultipleLast Updated:July 27, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Myeloma MultipleLast Updated:July 27, 2023Recruiting
Condition(s):Squamous Cell CarcinomaLast Updated:May 16, 2023Completed
Condition(s):NSCLCLast Updated:May 25, 2022Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:June 25, 2018Completed
Condition(s):Basal Cell Carcinoma (BCC)Last Updated:November 3, 2022Completed
Condition(s):Hepatocellular CarcinomaLast Updated:April 4, 2011Unknown status
Condition(s):Pancreatic CancerLast Updated:April 10, 2017Completed
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:February 12, 2024Recruiting
Condition(s):Mesothelioma; Uveal Melanoma; Renal Cell Carcinoma; CholangiocarcinomaLast Updated:September 15, 2023Completed
Condition(s):Breast CancerLast Updated:January 7, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.